NeoGenomics, Inc.
Market Cap
$214.71M
P/E Ratio
-9.85
EPS
$-0.84
Dividend Yield
0.00%
52-Week Range
$4.72 — $13.74
Volume
964.96K
Avg Volume
1.89M
Beta
1.64
P/E (TTM)
-9.85
Forward P/E
48.14
PEG Ratio
-0.42
P/S (TTM)
0.28
P/B (TTM)
0.25
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.13%
ROA (TTM)
-0.08%
ROIC
—
Gross Margin
0.42%
Operating Margin
-0.16%
Net Margin
—
Debt/Equity
0.56
Current Ratio
4.26
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-5.05%
EPS Growth (5Y)
-3.70%
Sales Growth (3Y)
+0.11%
Sales Growth (5Y)
+0.10%
EPS Est (This Year)
$0.17
EPS Est (Next Year)
$0.36
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$6.20
Price Target Range
Consensus Target: $12.50(51.1% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
-22128
Outstanding Shares
25.88M
Float
24.61M
Free Float %
95.11%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
NASDAQ
IPO Date
2004-03-16
Employees
2200
CEO
Anthony Zook
Index Membership
—
Website
https://www.neogenomics.com
NeoGenomics, Inc. (NEO) is a healthcare company in the medical - diagnostics & research industry listed on the NASDAQ. With a market capitalization of $214.71M, a P/E ratio of -9.85, NEO is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare NEO against other stocks using dozens of fundamental and technical filters.
NeoGenomics, Inc. (NEO) has a trailing twelve-month (TTM) P/E ratio of -9.85. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, NeoGenomics, Inc. (NEO) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
NeoGenomics, Inc. (NEO) has a market capitalization of $214.71 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.